Ugandan wins Africa prize for bloodless malaria test
bbc.com
bbc.com
And worries about production, commercialization and raising funds in a VC-less environment are bothering these guys what advice would you give them?
How would they outsource production or fabrication without large capital?
Can they sell their device for cash and then produce on demand?
I'm asking because once in a while, I read about smart creations from different African nations. In the interviews, a common complaint is "If we can get a sponsor..." And that's where their story ends.
Note: African esp. West African transactions is heavily cash based. So crowdfunding is out of the question?
South Africa is moribund by comparison.
Isn't that what stock markets are for?
For things like malaria treatments, there are tons of international funds, public and private. I mean, one of the biggest, the Gates foundation, has plenty of funds for this kind of programs.
Also, a lot of people overestimate the cost of outsourcing manufacturing. A few plane tickets and a few weeks of hostel in Shenzhen with the good people will put you on track to manufacture many devices and probably enough for the 1.0 version that you will sell in a volume of mere thousands.
You don't need millions of dollars and volumes of millions. Not anymore.
Call Bill Gates /his foundation if he hasn't called you already. You'll walk out rich and with the satisfaction that you're saving tens of million lives.
The Plasmodium parasite doesn't seem to have any special characteristics (ie size, spectral response) that would make it detectable by such a device. You can skip the sample size issue by assuming the diagnostic will run for hours or days, but I don't see any theoretical foundation this device could be based on.
Also the obsession of the website with the smartphone interface is kind of sketchy and makes it look (more) like a scam to me.
Edit: I looked further into it, the price is given by the royal academy of engineering. Taken from their website [1]:
" Gitta wins the first prize of UK £25,000 (124 million Ugandan shillings). At an awards ceremony in Nairobi, Kenya on 13 June 2018, four finalists from across sub-Saharan Africa delivered presentations, before Africa Prize judges and a live audience voted for the most promising engineering innovation."
Which means that a live audience of non-technical people were involved in the choice, and, to my opinion, from the rest of the content, this is a feel-good kind of competition with soft goals like promoting innovation and training young people, not the kind of competition that awards working ideas.
[1] https://www.raeng.org.uk/news/news-releases/2018/june/uganda...
Its red beam can detect changes in the colour, shape and concentration of red blood cells - all of which are affected by malaria.
So that particular line of cynicism is more illiterate than it is cynical.
Theranos was also looking at only tiny amounts of blood drawn from a finger prick. And everyone was on that bandwagon, as you are now. And telling the others to shut-up and not dare to "wrong-think".
That's why I objected to the "harsh" tone. It is an application of PC thinking.
This is far from getting funded, it's a technical concept and we have absolutely no ability or relevant information upon which to call it a fraud.
You are the only one trying to make this about "PC thinking".
The article, however, explains how the actual proposed means of operation is based on measuring actual symptoms of the illness — observable changes to the red blood cells — which is at least somewhat compatible with the mechanics of a pulse oximeter, and, therefore, not entirely unreasonable.
The tone was harsh not because of the cynicism, but because said cynicism was based on a concern that wouldn't even have been there if the OP had RTFA.
But I would say that the bandwagon jumping is where everyone that makes any claim about a medical device is being compared to the billion dollar fraudsters, even if they have not brought the claim to market or committed any fraud.
https://www.google.com/amp/s/www.newscientist.com/article/dn...
I currently live in North Africa and if developing anything for this market I'd do "phones first, tablets second" and not even bother with a desktop version.
In some contexts a less invasive, easier to do, or just plain cheaper test can make sense for screening even if it's not good enough to replace your other tests. So there's a middle ground between "replaces blood tests for malaria" and useless.
My pathologist friend was telling me that because machines are still very bad at figuring out if cells from a smear might be cancer but very good at figuring out if a sample has HPV fragments they've switched to letting the machines check samples for HPV and then, since cervical cancer is almost invariably caused by HPV a human looks at the smears for the HPV positive patients to search for cancer. Humans aren't great at this either, but this approach means each individual worker spends more time looking at the smears that actually might have cancer, so hopefully that lets them do a better job.
https://www.azcentral.com/story/news/local/arizona/2018/06/0...
Understand the shade you are throwing!